<code id='8C5FA621E6'></code><style id='8C5FA621E6'></style>
    • <acronym id='8C5FA621E6'></acronym>
      <center id='8C5FA621E6'><center id='8C5FA621E6'><tfoot id='8C5FA621E6'></tfoot></center><abbr id='8C5FA621E6'><dir id='8C5FA621E6'><tfoot id='8C5FA621E6'></tfoot><noframes id='8C5FA621E6'>

    • <optgroup id='8C5FA621E6'><strike id='8C5FA621E6'><sup id='8C5FA621E6'></sup></strike><code id='8C5FA621E6'></code></optgroup>
        1. <b id='8C5FA621E6'><label id='8C5FA621E6'><select id='8C5FA621E6'><dt id='8C5FA621E6'><span id='8C5FA621E6'></span></dt></select></label></b><u id='8C5FA621E6'></u>
          <i id='8C5FA621E6'><strike id='8C5FA621E6'><tt id='8C5FA621E6'><pre id='8C5FA621E6'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          entertainment

          author:explore    - browse:4499
          A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT
          Adobe

          The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

          Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

          advertisement

          Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          hotspot